7602
C.-L. Zou et al. / Tetrahedron 64 (2008) 7594–7604
(3H, t, J¼7.2 Hz, NCH2CH3), 3.28 (3H, s, OCH3), 3.70 (1H, t, J¼6.4 Hz,
H-1 ), 5.11,
), 3.76–3.90 (1H, m, H-16), 4.89 (1H, t, J¼4.8 Hz, H-14
5.22 (each 1H, s, OCH2O); 13C NMR (100 MHz, CDCl3)
81.9 (d, C-1),
26.2 (t, C-2), 34.3 (t, C-3), 45.6 (s, C-4), 50.6 (d, C-5), 75.6 (d, C-6),
90.7 (s, C-7), 81.3 (s, C-8), 49.6 (d, C-9), 78.7 (s, C-10), 52.2 (s, C-11),
36.5 (t, C-12), 38.6 (d, C-13), 72.0 (C-14), 35.3 (t, C-15), 71.1 (d, C-16),
63.3 (d, C-17), 21.7 (q, C-18), 173.0 (s, C-19), 42.2 (t, C-21), 12.5 (q, C-
22), 55.2 (q, C-10), 93.4 (t, OCH2O); ESIMS m/z 452 [MþH]þ; HR-
ESIMS [MþNa]þ m/z calcd for C23H33NO8Na: 474.2098, found:
474.2075.
2.93–2.98, 3.97–4.04 (each 1H, m, NCH2CH3), 3.09 (3H, s, OMs), 3.26
(3H, s, OCH3), 3.63 (1H, d, J¼3.2 Hz, H-17), 3.74 (1H, d, J¼5.6 Hz,
b
b
d
H-9), 3.77 (1H, t, J¼8.8 Hz, H-1
b
), 4.21 (1H, d, J¼0.8 Hz, H-6
a
), 5.06,
), 5.49
), 7.44–8.11 (5H, m, Ar–H); 13C NMR
82.6 (d, C-1), 26.6 (t, C-2), 33.0 (t, C-3), 45.4 (s,
5.24 (each 1H, s, OCH2O), 5.11 (1H, dd, J¼9.2, 2.4 Hz, H-16
(1H, t, J¼5.2 Hz, H-14
(100 MHz, CDCl3)
a
b
d
C-4), 51.0 (d, C-5), 78.8 (d, C-6), 93.3 (s, C-7), 81.4 (s, C-8), 49.2 (d, C-
9), 79.5 (s, C-10), 53.5 (s, C-11), 36.5 (t, C-12), 38.8 (d, C-13), 75.1 (d,
C-14), 34.7 (t, C-15), 72.1 (d, C-16), 62.5 (d, C-17), 21.8 (q, C-18),
173.2 (s, C-19), 43.1 (t, C-21), 12.4 (q, C-22), 55.0 (q, C-10), 93.8 (t,
OCH2O), 166.1 (s, Ar–COO), 130.0 (s, C-100), 129.7 (d, C-200, 600), 128.5
(d, C-300, 500), 133.2 (d, C-400), 38.3 (q, OMs); ESIMS m/z 634 [MþH]þ;
4.1.4. Preparation of compounds 5a and 5b
To a solution of 4 (2.3 g, 5.10 mmol) in fresh THF (100 ml), were
added sequentially KI (169 mg, 1.02 mmol), Ag2O (1.77 g,
7.65 mmol), and BzCl (1.1 ml, 9.18 mmol) under argon steam and
the mixture was heated at 40 ꢁC for 2 h, to which water (3 ml) was
added to stop the reaction. A general work-up procedure gave
a residue, which was diluted with H2O (20 ml). Basifying (NH4OH,
pH 10), extraction (CHCl3, 30 mlꢄ3), drying (Na2SO4), evaporation,
and column chromatography (silica gel H, 75 g, CHCl3–MeOH 95:5
to 19:1) furnished 5a (1.27 g, 45%, after recovering the starting
material from 5b, 90%) and 5b (1.42 g, 50%). The latter was hydro-
HR-ESIMS [MþNa]þ m/z calcd for C31H39NO11SNa: 656.2136, found:
20
656.2108. Compound 7: mp: 68–70 ꢁC; [
a
]
D
þ22.6 (c 0.5, CHCl3); IR
(KBr): 3518, 3389, 1683, 1642 cmꢀ1; 1H NMR (400 MHz, CDCl3) and
13C NMR (100 MHz, CDCl3) see Table 1; ESIMS m/z 434 [MþH]þ; HR-
ESIMS [MþNa]þ m/z calcd for C23H31NO7Na: 456.1993, found:
456.1982.
4.1.6. Preparation of the key intermediate 8
The olefin-ketone 8, employed as the key intermediate, could be
synthesized by one-pot mesylation–Grob fragmentation–methyl-
ation procedure. Alcohol 5a (1.65 g, 2.97 mmol) was first mesylated
with MsCl (0.82 ml, 8.91 mmol) in dry pyridine (60 ml) at room
temperature for 2 h, then exposed to 5% sodium hydroxide–
methanol (60 ml) under reflux for 3 h. Finally, the C-6 and C-16
hydroxyl groups were protected using CH3I (1.65 ml, 26.10 mmol)
and NaH (935 mg, 39.14 mmol) in THF (50 ml) at room temperature
for 4 h (TLC monitoring). Adding H2O to stop the reaction, and the
usual work-up, followed by chromatography (silica gel H, 30 g;
lyzed with 5% NaOH methanol to recover the starting material 4 for
20
the next use. Compound 5a: mp: 148–150 ꢁC; [
a
]
ꢀ19.8 (c 0.5,
D
CHCl3); IR (KBr): 3422, 1712, 1623 cmꢀ1; 1H NMR (400 MHz, CDCl3)
d
1.16 (3H, t, J¼7.2 Hz, NCH2CH3), 1.29 (3H, s, H3-18), 2.93–2.98,
3.97–4.03 (each 1H, m, NCH2CH3), 3.25 (3H, s, OCH3), 3.43 (1H, d,
J¼5.2 Hz, H-9), 3.65 (1H, d, J¼3.2 Hz, H-17), 3.76 (1H, t, J¼8.4 Hz, H-
1
a), 4.18 (1H, br s, H-6
a
), 4.80 (1H, t, J¼4.8 Hz, H-14
b
), 5.05, 5.22
), 7.43–8.04 (5H, m,
82.2 (d, C-1), 26.5 (t, C-2), 33.3
(each 1H, s, OCH2O), 5.12–5.14 (1H, m, H-16
a
Ar–H); 13C NMR (100 MHz, CDCl3)
d
cyclohexane–acetone 7:1), furnished 8 (962 mg, 70%). Compound
20
(t, C-3), 45.4 (s, C-4), 50.8 (d, C-5), 75.3 (d, C-6), 90.4 (s, C-7), 82.4 (s,
C-8), 50.8 (d, C-9), 79.9 (s, C-10), 53.3 (s, C-11), 37.1 (t, C-12), 39.7 (d,
C-13), 73.4 (d, C-14), 34.4 (t, C-15), 71.5 (d, C-16), 62.6 (d, C-17), 21.7
(q, C-18), 173.7 (s, C-19), 43.1 (t, C-21), 12.3 (q, C-22), 55.0 (q, C-10),
93.8 (t, OCH2O),165.9 (s, Ar–COO),129.9 (s, C-100),129.5 (d, C-200, 600),
128.3 (d, C-300, 500), 133.1 (d, C-400); ESIMS m/z 556 [MþH]þ; HR-
8: mp: 67–69 ꢁC; [
a
]
þ30.6 (c 0.5, CHCl3); IR (KBr): 2935, 1699,
D
1649 cmꢀ1
;
1H NMR (400 MHz, CDCl3)
d
1.21 (3H, t, J¼7.2 Hz,
NCH2CH3), 1.30 (3H, s, H3-18), 3.20 (1H, dd, J¼10.0, 8.0 Hz, H-1
a
a
),
),
3.29, 3.30, 3.26 (each 3H, s, OCH3ꢄ3), 3.60 (1H, d, J¼12.0 Hz, H-6
3.85 (1H, t, J¼7.2 Hz, H-16), 4.21 (1H, d, J¼2.8 Hz, H-17), 2.70–2.79,
4.21–4.31 (each 1H, m, NCH2CH3), 4.89, 5.05 (each 1H, s, OCH2O),
ESIMS [MþNa]þ m/z calcd for C30H37NO9Na: 578.2361, found:
5.85 (1H, dd, J¼10.0, 6.8 Hz, H-14), 6.08 (1H, d, J¼10.0 Hz, H-9); 13
C
20
578.2338. Compound 5b: mp: 266–268 ꢁC; [
a
]
D
ꢀ18.0 (c 0.5,
NMR (100 MHz, CDCl3) d 81.8 (d, C-1), 26.3 (t, C-2), 36.0 (t, C-3), 43.0
CHCl3); IR (KBr): 3520, 3378, 1716, 1621 cmꢀ1
CDCl3)
;
1H NMR (400 MHz,
(s, C-4), 49.8 (d, C-5), 90.3 (d, C-6), 97.3 (s, C-7), 81.5 (s, C-8), 133.2
(d, C-9), 213.9 (s, C-10), 61.5 (s, C-11), 49.4 (t, C-12), 35.7 (d, C-13),
126.7 (d, C-14), 43.9 (t, C-15), 80.8 (d, C-16), 63.7 (d, C-17), 21.5 (q, C-
18),172.5 (s, C-19), 41.2 (t, C-21),12.5 (q, C-22), 55.9 (q, C-10), 57.9 (q,
C-60), 56.1 (q, C-160), 91.0 (t, OCH2O), ESIMS m/z 484 [MþNa]þ; HR-
ESIMS [MþNa]þ m/z calcd for C25H35NO7Na: 484.2306, found:
484.2295.
d
1.14 (3H, t, J¼7.2 Hz, NCH2CH3), 1.27 (3H, s, H3-18), 2.91–
2.96, 3.98–4.03 (each 1H, m, NCH2CH3), 3.22 (3H, s, OCH3), 3.60 (1H,
d, J¼2.8 Hz, H-17), 3.70 (1H, d, J¼4.8 Hz, H-9), 3.78 (1H, t, J¼8.8 Hz,
H-1
b
), 3.87 (1H, br d, J¼8.8 Hz, H-16
a), 5.10, 5.19 (each 1H, s,
OCH2O), 5.77 (1H, t, J¼4.8 Hz, H-14
b C
), 7.37–7.59 (5H, m, Ar–H); 13
NMR (50 MHz, CDCl3) 79.7 (d, C-1), 24.7 (t, C-2), 32.7 (t, C-3), 43.4
d
(s, C-4), 48.6 (d, C-5), 73.7 (d, C-6), 88.3 (s, C-7), 79.3 (s, C-8), 46.4 (d,
C-9), 78.0 (s, C-10), 51.0 (s, C-11), 36.0 (t, C-12), 38.3 (d, C-13), 72.7
(d, C-14), 35.3 (t, C-15), 68.3 (d, C-16), 60.8 (d, C-17), 20.1 (q, C-18),
171.1 (s, C-19), 40.5 (t, C-21), 10.7 (q, C-22), 91.6 (t, OCH2O), 53.2 (q,
C-10), 164.1 (s, Ar–COO), 128.8 (s, C-100), 127.9 (d, C-200,þ600), 126.8 (d,
C-300, 500), 131.2 (d, C-400); ESIMS m/z 556 [MþH] ; HR-ESIMS
[MþNa]þ m/z calcd for C30H37NO9Na: 578.2361, found: 578.2338.
4.1.7. Preparation of compound 9
To a solution of 8 (428 mg, 0.93 mmol) in t-BuOH–THF–H2O
(10:3:1, 15 ml) NMO (1.34 mg, 11.44 mmol) and OsO4 (64 mg,
0.25 mmol) were added and the reaction solution was stirred at
room temperature for 5 h, then, to this solution 10 ml of saturated
Na2SO3 solution was added and stirred vigorously for 15 min. The
removal of solvent, basification (NH4OH, pH 10), extraction (CHCl3,
4.1.5. Preparation of compounds 6 and 7
20 mlꢄ3), drying (Na2SO4), and evaporation afforded compound 9
20
Alcohol 5a (1.65 g, 2.97 mmol) was first mesylated with MsCl
(0.82 ml, 8.91 mmol) in dry pyridine (60 ml) at room temperature
for 2 h, stopping the reaction with H2O, and the usual work-up gave
6, and then exposed to 5% sodium hydroxide–methanol (60 ml)
under reflux for 3 h. Evaporation under reduced pressure, dilution
(H2O, 100 ml), extraction (CHCl3, 100 mlꢄ3), drying (Na2SO4), and
evaporation in vacuum gave a residue (1.29 g), followed by chro-
(460 mg, 100%). Compound 9: mp: 180–182 ꢁC; [
a]
þ43.2 (c 0.6,
D
CHCl3); IR (KBr): 3406, 2927, 1689, 1641 cmꢀ1
CDCl3)
;
1H NMR (400 MHz,
1.18 (3H, t, J¼7.2 Hz, NCH2CH3), 1.36 (3H, s, H3-18), 3.15 (1H,
d
dd, J¼10.0, 7.6 Hz, H-1
b
a
), 3.32, 3.34, 3.43 (each 3H, s, OCH3ꢄ3), 3.80
(1H, t, J¼8.8 Hz, H-16
), 4.21 (1H, t, J¼4.4 Hz, H-14), 4.39 (1H, d,
J¼3.2 Hz, H-17), 4.50 (1H, d, J¼5.2 Hz, H-9); 13C NMR (50 MHz,
CDCl3) d 81.2 (d, C-1), 26.2 (t, C-2), 35.4 (t, C-3), 43.9 (s, C-4), 49.3 (d,
matography (silica gel H, 25 g; cyclohexane–acetone 6:1) furnished
C-5), 92.4 (d, C-6), 95.4 (s, C-7), 81.3 (s, C-8), 68.9 (d, C-9), 212.0 (s,
C-10), 61.6 (s, C-11), 43.7 (d, C-12), 39.7 (d, C-13), 62.2 (d, C-14), 35.6
(t, C-15), 80.6 (d, C-16), 62.9 (d, C-17), 21.8 (q, C-18), 172.4 (s, C-19),
46.3 (t, C-21), 12.3 (q, C-22), 56.1 (q, C-10), 58.2 (q, C-60), 56.6 (q,
20
7 (1.13 g, 88%). Compound 6: mp: 152–154 ꢁC; [
a
]
D
ꢀ33.9 (c 0.8,
CHCl3); IR (KBr): 3412, 1713, 1623, 1354 cmꢀ1
;
1H NMR (400 MHz,
CDCl3)
d
1.16 (3H, t, J¼7.2 Hz, NCH2CH3), 1.30 (3H, s, H3-18),